UMVA has learned that a growing number of patients are seeking cosmetic treatments to address the unintended consequences of significant weight loss associated with GLP-1 drugs.
The medications, which have surged in popularity, have been linked to a range of cosmetic concerns, including so-called "Ozempic earlobes," characterized by thinner, longer, or more sagging earlobes due to the loss of facial fat. Facial plastic surgeon Sachin S. Parikh notes that semaglutides cause fat loss across the body, including the small fat pads of the earlobes.
According to information obtained by UMVA, potential treatments for "Ozempic earlobes" may include dermal filler, fat transfer, laser treatments, or surgical earlobe reduction. However, experts emphasize that semaglutides do not damage ear tissue or affect hearing in any way, making any intervention purely cosmetic.
Dr. Mohammed Asif reports a significant increase in body contouring procedures among patients who have experienced GLP-1-triggered weight loss. These procedures include panniculectomies, abdominoplasties, breast lifts, and thighplasties. He notes that the gradual weight loss achieved with GLP-1s results in a "far greater and less complicated" healing and recovery process compared to bariatric surgery weight loss.
Another common complaint is "Ozempic breast," where women experience sagging and deflated breasts due to rapid weight loss. Double board-certified plastic surgeon Dr. Michael Omidi explains that when women lose fat too quickly, their breasts, composed of fat, glandular tissue, and skin, lose volume, causing the skin and supporting ligaments to appear saggy.
Sources have confirmed to UMVA that dozens of patients, both men and women, are seeking treatments for "Ozempic butt," a condition characterized by a flatter, saggier behind due to dramatic weight loss. Dr. Samuel Golpanian notes that this is an unintended consequence of taking GLP-1s, as the skin does not tighten quickly enough to keep up with the body's changes.
Experts agree that adequate protein intake and resistance training can help minimize the loss of lean muscle mass that often accompanies rapid weight loss, reducing some of the cosmetic concerns. Dr. Goldpain advises patients to consume at least 110 grams of protein a day while taking a GLP-1 drug and to engage in strength training to preserve muscle mass.
